EURUSD Bid: --
USDJPY Bid: --
GBPUSD Bid: --
USDCHF Bid: --
AUDUSD Bid: --
USDCAD Bid: --
NZDUSD Bid: --
EURGBP Bid: --
GBPJPY Bid: --
WTI Bid: --
BRENT Bid: --
XAUUSD Bid: --
XAGUSD Bid: --
SPX500 Bid: --
DAX40 Bid: --
US30 Bid: --
JPN225 Bid: --
NAS100 Bid: --
UK100 Bid: --
BTCUSD Bid: --
ETHUSD Bid: --
LTCUSD Bid: --
XRPUSD Bid: --
EURUSD Bid: --
USDJPY Bid: --
GBPUSD Bid: --
USDCHF Bid: --
AUDUSD Bid: --
USDCAD Bid: --
NZDUSD Bid: --
EURGBP Bid: --
GBPJPY Bid: --
WTI Bid: --
BRENT Bid: --
XAUUSD Bid: --
XAGUSD Bid: --
SPX500 Bid: --
DAX40 Bid: --
US30 Bid: --
JPN225 Bid: --
NAS100 Bid: --
UK100 Bid: --
BTCUSD Bid: --
ETHUSD Bid: --
LTCUSD Bid: --
XRPUSD Bid: --

CME CEO Terry Duffy to Step Down, Board Names Lynne Fitzpatrick Successor

Posted: 17th Jun 2026

CME Group has announced a leadership transition that will see long-time Chief Executive Officer Terry Duffy step down in March 2027, ending a tenure that spans more than two decades at the top of the derivatives exchange operator.

The company said Duffy will move into the role of Executive Chairman, while current President and Chief Financial Officer Lynne Fitzpatrick will take over as CEO and join the board.

Leadership Transition Plan

Duffy has led CME Group since 2002, when he became Chairman, and later took on the CEO role in 2016. During his time in charge, the company expanded its global presence and reshaped its operations.

He oversaw CME’s transition from floor-based trading to electronic markets and led major acquisitions. These include the merger with the Chicago Board of Trade in 2007 and the purchase of the New York Mercantile Exchange in 2008. Both deals strengthened CME’s position in global derivatives trading.

Continue reading: CME to Launch Single Stock Futures on 50+ Major U.S. Shares, Including Nvidia and Tesla

The company has also grown in scale. CME reported average daily volumes of 28.1 million contracts last year and now has a market capitalization of more than $95 billion.

Duffy said he plans to remain active in the business during the transition. “I am pleased our company is well positioned and have never been more optimistic about its future potential,” he said.

Fitzpatrick to Take Over

Fitzpatrick will assume the CEO role after serving in several senior positions at CME. She became Chief Financial Officer in 2023 and was promoted to President and CFO in 2024. She joined the company in 2006 and previously worked in investment banking at Credit Suisse and UBS. CME said Duffy will continue to work closely with Fitzpatrick as Executive Chairman.

The most recent notable leadership transition at CME was the late‑2024 reshuffle where Lynne Fitzpatrick was promoted to President and Chief Financial Officer and Suzanne Sprague was elevated to Chief Operating Officer as longtime COO Julie Holzrichter moved into an advisory role.

That package of changes, coupled with the extension of Terry Duffy’s employment agreement through end‑2026, was framed by CME as a leadership update to support future growth of the derivatives franchise.

Meanwhile, CME recently announced plans to launch cash-settled single stock futures this summer, covering more than 50 major U.S. companies such as Nvidia, Tesla, Alphabet, and Meta. The move comes as demand for equity derivatives continues to grow among both institutional and retail investors.

The launch will still need to pass regulatory approvals before going live. The new contracts will track individual stocks from major indexes like the S&P 500, Nasdaq-100, and Russell 1000. Since they are cash-settled, traders will not own the actual shares but will instead trade on price movements. This setup allows investors to gain exposure to individual stocks using futures margin, rather than paying the full cost of buying the shares outright.

This article was written by Jared Kirui at www.financemagnates.com.

Source: Finance Magnates

Follow us on
Website Managed by BuiltByGo
Disclaimer: The information provided on FX Axe is for educational and informational purposes only and should not be construed as financial advice. Trading Foreign Exchange (FX), Contracts for Difference (CFDs), and other leveraged financial products involves a high level of risk and may not be suitable for all investors. Leverage can work both to your advantage and disadvantage, and as a result, you may lose more than your initial investment. Before deciding to trade FX, CFDs, or any other financial instrument, you should carefully consider your investment objectives, level of experience, and risk tolerance. You should not invest money that you cannot afford to lose. It is strongly advised that you seek independent financial advice if you have any doubts. FX Axe does not provide investment, tax, legal, or financial advice of any kind. We may receive compensation from brokers and partners featured on this website, but such relationships do not influence our reviews or recommendations. All reviews are based on our own opinions and research and should not be interpreted as endorsements or guarantees of any service. Past performance is not indicative of future results. The trading of FX and CFDs carries a significant risk of loss. By using this website, you acknowledge that FX Axe bears no responsibility for any losses you may incur from your trading activities or reliance on information provided here.

Affiliate Disclosure: Some of the links and references on FX Axe may relate to third-party brokers or service providers. In certain cases, we may receive compensation if you choose to engage with these providers through our website. This helps support the ongoing operation of the site and allows us to continue publishing content at no direct cost to our readers. Our content is created with the aim of being informative and useful. While commercial relationships may exist, we strive to ensure that the information presented remains objective and based on our own research and perspective.
cross